Market Research Blog

[250 Pages Report] As per the latest industry analysis by Future Market Insights, valuation of the global transcatheter mitral valve market was around US$ 831.1 Mn in 2021 and is projected to exhibit a CAGR of 13.5% over the forecast period. The market is expected to reach US$ 3.3 Bn in 2032.

Following the success and widespread use of transcatheter aortic valve replacement (TAVR), physician-investigators have turned their attention to percutaneous replacement of a diseased mitral valve (MV).

Attribute	Key Statistics
Global Transcatheter Mitral Valve Market Estimated Size (2022E)	US$ 933.9 Mn
Projected Market Valuation (2032F)	US$ 3.3 Bn
Value-based CAGR (2022-2032)	13.5%
Collective Value: Top 5 Countries (2021E)	80.1%

Get Sample Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-15165

However, while transcatheter aortic valve replacement (TAVR) has already established itself as the gold standard for treatment of aortic stenosis (AS) in patients who are at high risk for conventional surgery, transcatheter mitral valve replacement (TMVR) is yet to reach the same level.

MV disease is more frequent than AS, and surgical treatment for degenerative mitral regurgitation is still considered to be the gold standard. TMVR may evolve as a promising treatment alternative for patients with high surgical risk who are denied surgery and for whom medical therapy is insufficient.

Transcatheter mitral valve repair is a rapidly developing field that has the potential to be embraced as a viable alternative to surgery among certain patients. The targeted section of MV apparatus helps to recognize TMVR devices.

Need to transform a transapical treatment to a fully transcatheter (transfemoral and transeptal) procedure is set to surge in the upcoming decade on the back of rising number of preclinical programs under development.

Transcatheter therapies will need to follow stringent indications due to strict patient selection criteria for each device or use multiple procedures in a single repair process for severe MV disease to attain outcomes comparable to open surgery in degenerative mitral regurgitation.

Owing to the above-mentioned factors, the global transcatheter mitral valve market is set to gain traction among industry players.

Key Takeaways: Transcatheter Mitral Valve Market

• By product, the transcatheter mitral valve repair segment held approximately 4% of share in 2021 and is anticipated to lead in 2022-2032.
• Based on indication, the mitral regurgitation segment generated a transcatheter mitral valve market share of around 1% in 2021.
• By end user, the hospitals segment is expected to dominate the transcatheter mitral valve market with a projected CAGR of 6% during the forecast period.
• North America transcatheter mitral valve market generated a share of around 9% in 2021.
• Germany held a market share of about 2% in 2021 and is likely to remain at the forefront in the Europe transcatheter mitral valve market.

Ask from Market Research Expert@ https://www.futuremarketinsights.com/ask-question/rep-gb-15165

“Development of unique transcatheter mitral valve products and growing advancements in the field of degenerative mitral regurgitation are expected to push the global transcatheter mitral valve market in the forecast period,” says an analyst of Future Market Insights.

Competitive Landscape: Transcatheter Mitral Valve Market

The transcatheter mitral valve market is consolidated with the presence of various established players across the globe. Key players are enforcing clinical evaluations of pipelined products to strengthen their market positions. They are also investing huge sums in research and development activities to generate more revenues in the global market.

• In March 2022, Edwards Lifesciences received approval from the U.S. Food and Drug Administration (FDA) for its MITRIS RESILIA valve. It is a tissue valve replacement which is specifically designed for the heart’s mitral position.
• In April 2020, Abbott received the CE Mark approval for its Tendyne Transcatheter Mitral Valve Implantation System and TriClip Transcatheter Tricuspid Valve Repair System under its structural heart device portfolio.

More Valuable Insights on Transcatheter Mitral Valve Market

Future Market Insights offers a unique perspective and actionable insights on the transcatheter mitral valve market in its latest study, presenting a historical demand assessment of 2017 – 2021 and projections for 2022 – 2032.

The research study is based on product (transcatheter mitral valve replacement and transcatheter mitral valve repair), indication (mitral stenosis and mitral regurgitation), and end user (hospitals, ambulatory surgical centers, and cardiac catheterization laboratories) across seven key regions of the world.

For in-depth insights, Download a PDF Brochure@ https://www.futuremarketinsights.com/reports/brochure/rep-gb-15165

Transcatheter Mitral Valve Market Outlook by Category

By Product:

• Transcatheter Mitral Valve Replacement
• Transcatheter Mitral Valve Repair

By Indication:

• Mitral Stenosis
• Mitral Regurgitation

By End User:

• Hospitals
• Ambulatory Surgical Centers
• Cardiac Catheterization Laboratories

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

[225 Pages Report] Steroid-free nasal sprays are medications that are directly delivered to nasal cavities with the avoidance of first-pass metabolism and also provide better bioavailability. It includes nasal antihistamine sprays, nasal decongestant sprays, nasal anticholinergic sprays, and nasal cromolyn sodium sprays.

As per Future Market Insights’ latest industry analysis, the global steroid-free nasal sprays market was valued at over US$ 7.75 Bn in 2021 and is expected to exhibit a CAGR of 6.3% over the forecast period, pushing the market size to US$ 14.9 Bn by 2032.

Data Points	Market Insights
Steroid-free Nasal Sprays Market Base Yea Value (2021)	US$ 7.7 Bn
Estimated Market Size (2022)	US$ 8.1 Bn
Projected Market Valuation (2032)	US$ 14.9 Bn
Value-based CAGR (2022-2032)	6.3%
Share of Top 5 Countries	57.9%

There is a subsequent rise in the prevalence of allergic rhinitis worldwide due to several risk factors including urbanization and environmental pollutants. According to a recent study conducted in 2022, allergic rhinitis affects about 25% to 40% of the population worldwide. It also states that approximately 80% of allergic rhinitis symptoms develop before the age of 20.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15127

Recently, there has been an increasing emphasis on mental illnesses due to the significant rise in cases of major depressive disorders. Among these, depression is a common mental disorder. According to WHO, approximately 280 million people of all ages suffer from depression.

Due to rising adverse effects of depression, manufacturers in the steroid-free nasal sprays market are focusing on introducing products that can be used for the treatment of these disorders in the most effective manner.

Moreover, an increased number of regulatory approvals have been observed in the steroid-free nasal sprays market which is propelling the launch of innovative products. Therefore, manufacturers in the market are focusing on getting regulatory approvals to improve sales in the market.

“Rising availability of generic nasal sprays, along with increasing promotional activities by manufacturers at online channels will boost sales of steroid-free nasal sprays over the assessment period,” says an FMI analyst.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-15127

Key Takeaways:

• Based on product type, sales of nasal antihistamine sprays will increase at a 5.9% CAGR through 2032.
• The aqueous by formulation segment dominated the steroid-free nasal sprays market with around 4% share in 2021.
• In terms of distribution channels, demand in the institutional segment will grow at a 6% CAGR through 2032.
• North America accounted for the highest share of 6% of the global steroid-free nasal sprays market share in 2021.

Competition Landscape

Prominent players operating in the global steroid-free nasal sprays market are focusing on the development, launch, and approval of innovative products to improve their product portfolios. For instance:

• In February 2022, Glenmark Pharmaceuticals Limited along with SaNOtize Research & Development Corp. announced the launch of FabiSpray, the nitric oxide nasal spray for the treatment of COVID-19 in India.
• In March 2021, Cipla Limited announced that it has received final approval from the FDA for its abbreviated new drug application (ANDA) for Sumatriptan Nasal Spray, 20 mg which is an AB-rated generic therapeutic equivalent version of GlaxoSmithKline’s Imitrex nasal spray.

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the steroid-free nasal sprays market in its latest study, presenting a historical demand assessment of 2017 – 2021 and projections for 2022 – 2032. The global steroid-free nasal sprays market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

The steroid-free nasal sprays market is segmented into three parts based on the product (nasal antihistamine sprays, nasal decongestant sprays, nasal anticholinergic sprays, nasal cromolyn sodium sprays, and others), formulation (aqueous, suspension, nonaqueous-based solution, hydroalcoholic, emulsions, and dry powder/micro particles) and distribution channel- (institutional sales {hospitals, specialty clinics, community clinics, public health agencies, and others}, retail sales {retail pharmacy, drug stores, mail order pharmacy}), across seven key regions of the world.

Key Players :

• Janssen Pharmaceutical, Inc.
• Astra Zeneca Plc.
• Cipla Ltd.
• Glenmark Pharmaceuticals
• Glaxosmithkline Plc.
• Novartis International AG
• Procter & Gamble
• Sanofi S.A. (Sanofi-aventis LLC.)
• Boehringer Ingelheim GmbH
• AdvaCare Pharma
• Bayer AG (Bayer Consumer Health
• Covis Pharma S.a.r.l.
• Nipro Corporation (NIPRO JMI Pharma Ltd.)
• Viatris Inc. (Meda Pharmaceuticals Inc.)
• Perrigo Company plc
• AptarGroup, Inc.
• Berry Global, Inc.
• URSATEC GmbH
• Gerresheimer AG
• Avantor, VWR International, LLC
• Spectrum Laboratory Products, Inc.  (Spectrum Pharmacy Products)
• SKS Bottle & Packaging, Inc.
• Coster Tecnologie Speciali S.p.A

Request Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-15127

Steroid-Free Nasal Sprays Market by Category

By Product:

• Nasal Antihistamine Sprays
• Nasal Decongestant Sprays
• Nasal Anticholinergic Sprays
• Nasal Cromolyn Sodium Sprays
• Others

By Formulation:

• Aqueous
• Suspension
• Nonaqueous-Based Solution
• Hydroalcoholic
• Emulsions
• Dry Powder/Micro Particles

By Distribution Channel:

• Institutional Sales
  • Hospitals
  • Specialty Clinics
  • Community Clinics
  • Public Health Agencies
  • Others
• Retail Sales
  • Retail Pharmacy
  • Drug Stores
  • Mail Order Pharmacy

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Future Market Insights, in its latest business report, elaborates on the current situation of the global Non Fusion Spinal Devices market in terms of volume, value, production, and consumption.

The report scrutinizes the market into various segments, end uses, regions, and players on the basis of demand patterns, and future prospects.

Non Fusion Spinal Devices market players – Medtronic Inc., Stryker Corporation, Zimmer Holdings Inc., DePuy Synthes, among others represent the global Non Fusion Spinal Devices market.

The market study depicts an extensive analysis of all the players running in the Non Fusion Spinal Devices market report based on distribution channels, local network, innovative launches, industrial penetration, production methods, and revenue generation.

Further, the market strategies and mergers & acquisitions associated with the players are enclosed in the Non Fusion Spinal Devices market report.

Get a Sample Copy of Report @
https://www.futuremarketinsights.com/reports/sample/rep-gb-582
Understanding the Impact of Covid-19 on Healthcare Industry

With the pandemic plaguing maximum countries across the globe, healthcare industry is witnessing its fair share of ‘ups and downs’.

The COVID-19 has placed an enormous strain on the healthcare sector’s workforce, facilities and infrastructure.

Despite the endless pressure, healthcare sector is growing at a moderate pace due to the improvement in infrastructure and advancement in technology, healthcare sector is delivering a healthy performance.

The FMI’s latest report on the Non Fusion Spinal Devices market gives a detailed analysis on the impact of COVID-19 with an incisive coverage on the innovative strategies adopted by the market players to survive the challenges due to pandemic.

Request Report Methodology @
https://www.futuremarketinsights.com/askus/rep-gb-582
Non Fusion Spinal Devices Market: Segmentation

Artificial Discs Replacement

• Cervical Discs Replacement
• Lumber Discs Replacement

Dynamic Stabilization Devices

• Interspinous Process Decompression (IPD) Devices
• Pedicle Screw-Based Dynamic Stabilization Systems
• Annulus Repair Devices

Regional analysis includes

• North America (U.S., Canada)
• Latin America (Mexico. Brazil)
• Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
• Eastern Europe (Poland, Russia)
• Asia Pacific (China, India, Australia & New Zealand)
• Japan
• Middle East and Africa (S. Africa, N. Africa)

Ask Us Your Questions About This Report @
https://www.futuremarketinsights.com/ask-question/rep-gb-582

Report Highlights:

• Detailed overview of parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint.

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

[341 Pages Report] Cancer, cardiovascular diseases, and metabolic diseases like diabetes, are the main cause of mortality and disability in present times. Even with the understanding of scientific disease indications, it is crucial to elevate diagnosis and control the symptoms and signs of illness.

According to the Future Market Insights’ analysis, the injectable drugs market is set to grow at a 5.8% CAGR over the assessment period. As per the report, the market is projected to be valued at US$ 937.0 Bn by the end of 2032.

Advancements in technologies that involve optimization of the devices used for clinical conditions, be it chronic or acute, clinical innovations, bringing in minimally invasive treatments, and evolvement in clinical diagnostics and management in treating high-risk patients, are the key developments within the general healthcare industry.

To remain ahead of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15073

Demand for related treatments is increasing, as people are now more aware of the right treatment options, doctor-guided plans, and precautionary measures to consider for serious clinical conditions.

Key players in the injectable drugs market are actively seeking to gain approvals from regulatory bodies, and develop products across the continuum of care in severe case recovery. Furthermore, the FDA is expected to approve new devices related to advanced injectable drugs and their administration, over the coming years.

“Increasing incidence of infectious diseases, oncological diseases, cardiac disorders and device innovation are prompting healthcare providers to incorporate new treatment regimens for improved patient outcome,” says an FMI analyst.

Key Takeaways:

• By product, monoclonal antibodies held the largest share of 5% in the global market in 2021.
• Based on application, infectious diseases segment held the largest share of 4% in the global market in 2021, with the segment expected to expand at 5.7% CAGR over the forecast period.
• In terms of molecule, large molecule segment held the largest share of 8% in the global market in 2021.
• By route of administration, sales in the intravenous (IV) segment are expected to increase at a 3% CAGR over the assessment period.
• Based on distribution channel, the hospital pharmacies segment was valued at US$ 231.0 Bn in 2021.
• North America held the largest share of 5% in the global injectable drugs treatment market in 2021, owing to the growing government investments in healthcare and R&D activities.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-15073

Competitive Landscape

Product launches and collaborations with suppliers that have a strong position and are popular in the market are some of the key strategies of the market players operating in the global injectable drugs market. For instance:

• Merck and Gilead Sciences, Inc. (Gilead) signed an agreement in March 2021 to collaborate on the development and commercialization of long-acting HIV treatments that combine Merck’s investigational nucleoside reverse transcriptase translocation inhibitor islatravir and Gilead’s investigational capsid inhibitor lenacapavir.
• In March 2022, Sanofi IGM Biosciences, Inc. today announced the signing of an exclusive worldwide collaboration agreement to create, develop, manufacture, and commercialize IgM antibody agonists against three oncology targets and three immunology/inflammation targets. Engineered IgM antibodies represent a new class of potential therapeutics that combine the multi-valency of IgM antibodies possessing 10 binding sites compared to conventional IgG antibodies having only 2 target binding sites.
• In February 2022, Novartis India Limited extends access to its medicines in India by signing exclusive sales and distribution agreement with Dr. Reddy’s Laboratories

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the injectable drugs market in its latest study, presenting a historical demand assessment of 2014 – 2021 and projections for 2022 – 2032.

The research study is based on the product – (monoclonal antibodies, immunoglobulin, cytokines, insulin, peptide hormones, blood factors, peptide antibiotics, vaccines, small molecule antibiotics, chemotherapy agents, and others), by application (oncology, infectious diseases, diabetes, blood disorders, hormonal disorders, musculoskeletal disorders, CNS diseases, pain management, and cardiovascular diseases), by molecule type (small molecules and large molecules), by route of administration (intravenous (IV), intramuscular (IM), and subcutaneous (SC)), by distribution channel (hospital pharmacies, retail pharmacies, drug stores, and online pharmacies), across seven key regions of the world.

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-15073

Key Players :

• Pfizer Inc.
• Teva Pharmaceutical Industries Ltd.
• Sanofi S.A.
• Sun Pharmaceutical Industries Ltd.
• AstraZeneca Plc
• Merck & Co., Inc.
• Viatris + Mylan N.V
• Cipla Inc.
• Dr. Reddy’s Laboratories Ltd.
• Samsung Biologics
• Abbott Laboratories
• Amgen Incorporated
• Baxter International Incorporated
• Becton Dickinson and Company
• Bristol-Myers Squibb Company
• GlaxoSmithKline Plc
• Roche Holding Limited

Key Segments Covered in Injectable Drugs Industry Research

By Product:

• Monoclonal Antibodies
• Immunoglobulin
• Cytokines
• Insulin
• Peptide Hormones
• Blood Factors
• Peptide Antibiotics
• Vaccines
• Small Molecule Antibiotics
• Chemotherapy Agents
• Others

By Application:

• Oncology
• Infectious Diseases
• Diabetes
• Blood disorders
• Hormonal Disorders
• Musculoskeletal Disorders
• CNS Diseases
• Pain Management
• Cardiovascular Diseases

By Molecule Type:

• Small Molecules
• Large Molecules

By Route of Administration:

• Intravenous (IV)
• Intramuscular (IM)
• Subcutaneous (SC)

By Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Drug Stores
• Online Pharmacies

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

[322 Pages Report] The smart wheelchair market is subject to changes owing to the factors influencing the market such as the increasing prevalence of neurological disorders, rising awareness and demand for automated medical devices, increasing burden of the geriatric population globally, and the growing levels of disposable income of the target population.

According to the latest study conducted by Future Market Insights, the smart wheelchair market will be projected to be valued at US$ 162.6 Mn by the end of 2022 and is expected to exhibit a CAGR growth of 7.8% over the forecast period (2022-2032)

Although the independent movement is crucial, some wheelchair users find it difficult or impossible to operate conventional manual or motorised wheelchairs. Multiple overlapping physical, cognitive, or perceptual symptoms of diseases such as cerebral palsy, amyotrophic lateral sclerosis, cerebrovascular accident, multiple sclerosis, and spinal cord injury can make it difficult to use a wheelchair safely and independently. Varied forms of assistance from a smart wheelchair and different wheelchair form elements can benefit people with various symptom combinations.

Get Sample Report@  https://www.futuremarketinsights.com/reports/sample/rep-gb-15035

The COVID-19 pandemic had unprecedented effects on the world’s economy, along with sending the healthcare sector into a hyper drive. COVID-19 pandemic negatively influenced the smart wheelchair market during the peak of the pandemic in 2020, due to the shortage of supply of raw materials and other supply chain crises. However, the partial normalization of the world in 2021 opened up a foray of growth opportunities for the key players in this industry.

There are services in hospital settings where external consultations, tests, analyses, and procedures are conducted involving patient displacement. This is particularly important for those with balance and mobility issues caused by disability, pain, fractures, or abnormalities in the lower limbs. Patients are currently transported to hospitals by patient transporters. It could often be done in a wheelchair, which would be more beneficial, owing to its autonomy. As a result, delays and failures owing to a shortage of staff to carry out the transfer would be avoided.

Technological advancements are also shaping the growth of the smart wheelchairs industry for over a decade.

• For instance, In November 2021, Sunrise Medical LLC. announced the launch of its new ZIPPIE® Sphynx™ an on the go, compact, easily transportable wheelchair that can fit within a compact car’s trunk according to the clients’ needs. The market is consolidated with a few key players dominating the industry.

Rising sedentary lifestyle, increasing popularity of ultra-lightweight smart wheelchairs, and increased focus on R&D for smart wheelchairs are some of the key trends of this market. The overall improved technology adoption globally will fuel the demand for smart wheelchairs and the market is likely to expand exponentially over the forecast period. (2022-2032)

Ask from Market Research Expert@ https://www.futuremarketinsights.com/ask-question/rep-gb-15035

Key Players :

• Medical Depot, Inc.
• Permobil AB
• Pride Mobility Products Ltd.
• MEYRA GmbH
• DEKA Research & Development Corp.
• tmsuk company limited
• Ottobock
• WHILL Inc.
• Invacare Corporation
• Karman Healthcare, Inc.

Key Takeaways from this study:

• The joystick based smart wheelchairs hold the highest market share of about 0% during the year 2021, expanding at a CAGR of 7.6% during the forecast period.
• Mobility impairment by usage accounts for the largest market value share of more than 40% and is set to expand at a CAGR of 2%.
• The healthcare settings as the end users hold a market share of 0% in 2021 with an expected CAGR growth of 6.8% during the forecasted years.
• North America is a leading region for the global smart wheelchairs market during the year 2021, accounting for a market share of 0%.

“Growing patient awareness regarding smart wheelchairs would fuel the growth of this market globally” says an analyst of Future Market Insights.

Market Competition:

Acquisitions and expansion of existing facilities are some of the strategies adopted by leading manufacturers of the smart wheelchair industry such as Sunrise Medical and Permobil, to further their business and establish a stronger market presence.

• In August 2020, Sunrise Medical announced the completion of a strategic acquisition of paediatric industry leaders, Leckey and Firefly, in order to extend its paediatric product and service portfolio.
• In March 2022, Permobil, a leading player in the wheelchairs industry, announced an investment to expand their R&D and operations facility in Tennessee in order to expand their business.

For in-depth insights, Download a PDF Brochure@ https://www.futuremarketinsights.com/reports/brochure/rep-gb-15035

What does the report cover?

Future Market Insights offers a unique perspective and actionable insights on the smart wheelchairs market in its latest study, presenting a demand assessment of 2017 – 2021 and projections for 2022 – 2032.

The research is based on product-(joystick based smart wheelchairs and Bluetooth connected smart wheelchairs), usage-(mobility impairment, ocular disability, geriatric group, multiple disability and others), and end-user (healthcare settings, home care settings and public access), and across seven key regions of the world.

About Healthcare Division at Future Market Insights

Future Market Insights facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you in devising innovation-driven trajectories for your business. Know more about our sector coverage here.

Key Market Segments Covered in the Smart Wheelchair Industry Research

By Product:

• Joystick based Smart Wheelchairs
• Bluetooth Connected Smart Wheelchairs

By Patient:

• Mobility Impairment
• Ocular Disability
• Geriatric Group
• Multiple-Disability
• Others

By End-User:

• Healthcare Settings
• Home Care Settings
• Public Access

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

[250 Pages Report] Ambulatory services, usually known as emergency medical services, are systems that provide medical care in emergency situations. Emergency medical services are primarily concerned with injury and acute illnesses such as stroke and cardiac arrest. Emergency medical services also cover services that are required in the event of a natural disaster.

The global emergency medical services market was valued at over US$ 19.3 Bn in 2021 and is expected to exhibit a CAGR of close to 6.2% over the forecast period (2022-2032).

Demand for emergency medical services is increasing as the number of cardiac arrests and accidents is rising across various countries. Software solutions that give technological breakthroughs in emergency medical services provide additional benefits such as forecasting future health hazards, improved communication during an emergency crisis, and real-time guidance during emergency scenarios.

Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14847

Growth in the emergency medical services market is influenced by various factors which include rising number of cases associated with infections, high risk of morbidity among the geriatric population, increasing investments and funding for medical services, growing volume of trauma cases, high healthcare expenditure, as well as a rise in the number of hospitals establishments worldwide.

Several other factors that influence the market for emergency medical services positively include the accessibility of emergency medical services through a well-developed transportation infrastructure, improved communication channels, robust software solutions, and growing activities related to procedural aid during emergency situations.

Additionally, the utilization of air ambulances, which are medical transport services that are essential in the event of a medical emergency, have promoted the growth of the emergency medical services industry.

“Rising adoption of air ambulances, along with growing demand for drone-based emergency medical services will augment the growth in the market,” says an FMI analyst.

Ask an Analyst @ https://www.futuremarketinsights.com/askus/rep-gb-14847

Key Takeaways:

· Advance life support services accounted for about 56.6% of the global market share in 2021, owing to the rise in demand due to the advent of the COVID-19 pandemic.

· As providers, hospital-based EMS held a dominant share of 27.4% in 2021. Hospital-based EMS provide pre-hospital care for patients during cases of emergency and trauma.

· Ground transport services are a dominant segment in terms of the fleet within the global market, carrying a market share of around 86.2% in 2021.

· North America is observed to be the leading region with an approximate value share of 35.6% in 2021.

Competition Landscape

Market expansion will be hampered by increasing vendor competition. Because there are so many brands and regional and local vendors, there are a lot of rivalries. Furthermore, suppliers in the emergency medical services industry are expanding their offerings to include mobile healthcare, medical educators, primary care extenders, and patient advocates. During the focused period, increased competition is expected to have a negative impact on the worldwide emergency medical service market growth. The emergency medical services industry is fragmented, and providers are competing by using both organic and inorganic growth techniques.

Report Customization available @ https://www.futuremarketinsights.com/customization-available/rep-gb-14847

Key Market Segments Covered in Emergency Medical Services Industry Research

By Services:

• Basic Life Support
• Advance Life Support
• Mortuary Services
• Patient Transfer Services

By Providers:

• Fire-Department-Based EMS
• Government EMS
• Hospital-Based EMS
• Private Ambulance Service
• Other EMS Agencies

By Fleet:

• Ground Transport
• Air Transport

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights (ESOMAR certified market research organization and a member of the Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favour the market growth in various segments based on Source, Application, Sales Channel and End-Use over the next 10-years.

Contact:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com

Website: https://www.futuremarketinsights.com

LinkedIn| Twitter| Blogs

The global DNA diagnostics market is estimated to garner US$ 51.5 Billion while exhibiting an 8.4% CAGR during the forecast period. The growing support from several governments is likely to fuel the market growth in the coming years. The industry is expected to secure US$ 22.9 Billion in 2022.

Increasing government initiatives for research and development for treatment of chronic diseases is expected to boost the growth of the DNA diagnostics market. Technological advancement in the diagnostic and treatment process of infectious diseases, propel the growth of the market in forecasting period. For instance, US government launched the “Cancer Moonshot” with the mission to accelerate the rate of progress against cancer to accelerate scientific discovery in cancer, foster greater collaboration, and improve the sharing of data.

The oncology segment is likely to offer remunerative opportunities for the global DNA diagnostics market. Several emerging economies are making significant developments in their healthcare budgets, thereby, providing lucrative opportunities to players in the market. For instance, as per CMS.gov, the U.S. health care spending grew 9.7% in 2020.

Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14700

Key Takeaways from the Market Study

· By application, the oncology segment is expected to record an 13.1% CAGR by 2032

· By product type, the instruments segment to expand at a 12.4% growth rate during the forecast period

· The U.S market to garner US$ 18.2 Billion and record an 8.2% CAGR from 2022-2032

· Market in China to procure US$ 3.6 Billion, expanding at a 7.8% growth rate during the assessment period

“Rising research and development in the field of biotechnology, increasing healthcare expenditure, also the growing demand for prenatal screening and new born testing which will benefit the market in the forecast period,” says an FMI analyst.

Competitive Landscape

Eminent players in the global DNA diagnostics market include Sysmex, Bayer Diagnostic, Roche Diagnostics, Abbott Laboratories, Cephide Inc, among others. Recent key developments among players include:

· In February 2022, Sysmex Corporation announced a capital and business tie-up with KAINOS Laboratories, Inc., with a view toward strengthening capabilities to develop and produce diagnostic reagents in the immunochemistry field.

· In February 2020, Cepheid and Sherlock Biosciences announced a research collaboration to explore the development of new cutting-edge molecular diagnostic tests. Leveraging Sherlock Biosciences’ engineering biology platform, SHERLOCK™, a CRISPR-based technology that can identify virtually any genetic target, new tests could be designed to run on Cepheid’s GeneXpert® Systems. The collaboration will focus on molecular diagnostic tests for infectious diseases and oncology.

Ask an Analyst @ https://www.futuremarketinsights.com/askus/rep-gb-14700

Key Segments Covered in the DNA Diagnostics Industry Survey

DNA Diagnostics Market by Product type:

• DNA Diagnostics Instruments
• DNA Diagnostics Reagents
• DNA Diagnostics Software & Services

DNA Diagnostics Market by Technology:

• PCR-based DNA Diagnostics
• Microarray-based DNA Diagnostics
• In-situ Hybridization-based DNA Diagnostics
• Sequencing Technology-based DNA Diagnostics
• Mass Spectrometry-based DNA Diagnostics

Report Customization available @ https://www.futuremarketinsights.com/customization-available/rep-gb-14700

DNA Diagnostics by Application:

• DNA Diagnostics in Oncology
  • Prostate Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Others
• DNA Diagnostics in Infectious Diseases Treatment
  • Hepatitis B Virus
  • Hepatitis C Virus
  • HIV
  • TB
  • Chlamydia Trachomatic and Neisseria Gonorrhea (CT/NG)
  • HPV
  • Methiciline Resistant Staphylococcus Aureus (MRSA)
  • Others
• DNA Diagnostics in Myogenic Disorder Treatment
• DNA Diagnostics in Clinical Diagnostic Confirmation
• Prenatal DNA Diagnostics
• Pre-Implantation DNA Diagnostics
• DNA Diagnostics for Other Applications

DNA Diagnostics Market by End User:

• Point of Care DNA Diagnostics
• DNA Diagnostics across Diagnostic Centers
• Self-Testing/OTC DNA Diagnostics

DNA Diagnostics Market by Region:

• North America DNA Diagnostics Market
• Europe DNA Diagnostics Market
• Asia-Pacific DNA Diagnostics Market
• Middle East & Africa DNA Diagnostics Market
• Latin America DNA Diagnostics Market

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

[250 Pages Report] According to Future Market Insights (FMI), the demand for ocular drug delivery system is expected to rise considerably, enabling the market to surpass US$ 14,471.2 Mn in valuation by the end of 2021. The market is forecast to exhibit 6.8% CAGR between 2021 and 2031.

About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Ocular Drug Delivery Systems Market by Category

Technology

• Implantable Ocular Drug Delivery Systems
• Particulate Drug Delivery Systems
• Nano-Particle Drug Delivery System

Dosage Form

• Ophthalmic Solution
• Ophthalmic Suspension
• Ophthalmic Emulsion
• Ophthalmic Gels
• Ophthalmic Ointments

Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Drug Store
• Mail Order Pharmacies

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-6027

Region

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• Middle East and Africa (MEA)

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports : https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

As per Future Market Insights’ latest industry analysis, the U.S. animal model market was valued at over US$ 921.9 Mn in 2021 and is anticipated to exhibit a CAGR of close to 4.1% over the forecast period (2022-2032).

Animal models are predominantly used to gather information regarding the disease and its prevention, diagnosis, and treatment. They are being used to resolve a wide range of scientific concerns, ranging from basic science to the discovery and evaluation of new vaccines and therapies. Animals are used because of the similarities in biology across most mammals.

Get Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14527

Personalized medicine is also known as precision medicine which utilizes data about a specific patient or an individual’s genes to plan treatment for a disease. Animal models can play important role in the development of new approaches for personalized medicine. Increasing adoption of personalized medicine will drive sales of animal model in the forthcoming years.

Toxicity testing in animals is done to discover potential side effects from an agent’s exposure and to generate dose-response relationships. Animal testing is important for the early detection of the potential risk to humans or as models to study the causes, pathogenesis, progression, and treatment of diseases.

Organizations and legislations such as the Federal Food, Drug, and Cosmetic Act (FFDCA), Environmental Protection Agency (EPA), Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), and Organization for Economic Co-operation and Development (OECD) determine the testing guidelines for toxicity testing on animals.

Some factors such as the high production volume of chemicals testing in the U.S., increasing generation and utilization of novel GM animal strains in toxicity studies, and the development and attempted validation of several animal tests to screen chemicals for endocrine (hormone)-disrupting activity are expected to drive the growth in the market.

For in-depth insights, Download a PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14527

Key Takeaways:

• Based on species, the mice model segment is expected to hold nearly 62.6% of the total market share 2022, with sales growing at a 5.1% CAGR.
• In terms of therapeutics, the oncology accounted for more than 32.0% of the total market share in 2021, and the trend is expected to continue over the forecast period.
• By application, sales in the drug discovery/development segment commanded 65.4% of the total market share in 2021.
• Based on end user, the academic & research institutes segment accounted 36.6% of the total market share in 2021.

Key Players:

• Charles River Laboratories
• The Jackson Laboratory
• Taconic Biosciences, Inc.
• Genoway
• Envigo (Inotiv, Inc.)
• Marshall BioResources
• Janvier Labs
• Applied stem cells
• Biocytogen
• Transposagen Biopharmaceuticals, Inc. (Hera Bio Labs)
• Cyagen
• Ingenious targeting labs
• Crown Bioscience Inc. (JSR Corporation).
• Harbour Biomed
• Sinclair Bio Resources
• Alpha Genesis Inc.
• Creative Animodel
• DaVinci Biomedical Research Products, Inc

For in-depth competitive analysis, Buy Now @ https://www.futuremarketinsights.com/checkout/14527

Market Competition

Key players operating in the U.S. animal model market are expanding their business through partnerships and acquisitions with other companies to improve their global footprint. Following are a few examples of acquisitions:

• In October 2021, The Jackson Laboratory completed the acquisition of Charles River Laboratories Japan’s Research Models & Services (RMS), which allows advancement in the company’s scientific improvements in basic research and drug discovery.
• In November 2021, Inotiv, Inc., which is a leading contract research organization (CRO) completed its acquisition of Envigo RMS Holding Corp. to expand its R&D sector.
• In February 2021, Biocytogen completed the acquisition of a third Beacon Optofluidic system. This acquisition expanded Biocytogen’s service platform in the Boston area.

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the animal model market in its latest study, presenting a historical demand assessment of 2017–2021 and projections for 2022– 2032.

The research study is based on the species – (rats, mice, pigs, rabbits, monkeys, dogs, cats, other species), therapeutics- (metabolic diseases, cardiovascular diseases, neurological diseases, and oncology), application (drug discovery/development and basic & applied research) end-user (academic & research institutes, pharmaceutical companies, biotechnology companies, and CROs) and across seven key regions of the world.

Future Market Insights’ Expertise in Life Sciences and Transformational Health

Our expert team of industry analysts comprising management graduates, medical professionals, engineers, and project managers provides insights on emerging therapy areas, diagnostic tools, medical devices and components, reimbursement and market access, biotechnology, and life science research products and services to equip decision-makers with sound inputs and strategic recommendations.
About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports : https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs